Neovascularization after irradiation: What is the source of newly formed vessels in recurring tumors?

Journal of the National Cancer Institute

Volumn 104, Issue 12, 2012, Pages 899-905

  Kozin, Sergey V ^a   Duda, Dan G ^a   Munn, Lance L ^a   Jain, Rakesh K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BONE MARROW CELL; CANCER RADIOTHERAPY; CANCER RELAPSE; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIUM CELL; HUMAN; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR REGRESSION; TUMOR VASCULARIZATION;

ANIMALS; ENDOTHELIAL CELLS; HUMANS; MODELS, CARDIOVASCULAR; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TIME FACTORS;

EID: 84864152417     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs239     Document Type: Review

References (71)

1. Li F, Sonveaux P, Rabbani ZN, et al. Regulation of HIF-1alpha stability through S-nitrosylation. Mol Cell. 2007; 26 (1): 63-74. (Pubitemid 46550936)
2. Ahn GO, Brown JM. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell. 2008; 13 (3): 193-205. (Pubitemid 351318369)
3. Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest. 2010; 120 (3): 694-705.
4. Kozin SV, Kamoun W, Huang Y, Dawson MR, Jain RK, Duda DG. Recruitment of myeloid but not endothelial precursor cells facilitates tumor re-growth after local irradiation. Cancer Res. 2010; 70 (14): 5679-5685.
5. Gorski DH, Beckett MA, Jaskowiak NT, et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res. 1999; 59 (14): 3374-3378. (Pubitemid 29334495)
6. Hallahan DE, Chen AY, Teng M, Cmelak AJ. Drug-radiation interactions in tumor blood vessels. Oncology (Williston Park). 1999; 13 (10)(suppl 5): 71-77.
7. Duda DG, Kozin SV, Kirkpatrick ND, Xu L, Fukumura D, Jain RK. CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies? Clin Cancer Res. 2011; 17 (8): 2074-2080.
8. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004; 4 (1): 71-78. (Pubitemid 38082155)
9. Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer. 2008; 8 (8): 618-631.
10. Loges S, Schmidt T, Carmeliet P. "Antimyeloangiogenic" therapy for cancer by inhibiting PlGF. Clin Cancer Res. 2009; 15 (11): 3648-3653.
11. Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 2011; 11 (4): 239-253.
12. Liu SK, Bham SA, Fokas E, et al. Delta-like ligand 4-notch blockade and tumor radiation response. J Natl Cancer Inst. 2011; 103 (23): 1778-1798.
13. Budach W, Taghian A, Freeman J, Gioioso D, Suit HD. Impact of stromal sensitivity on radiation response of tumors. J Natl Cancer Inst. 1993; 85 (12): 988-993. (Pubitemid 23177585)
14. Denekamp J. Limited role of vasculature-mediated injury in tumor response to radiotherapy. J Natl Cancer Inst. 1993; 85 (12): 935-937.
15. Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell. 2005; 8 (2): 89-91. (Pubitemid 41132735)
16. Garcia-Barros M, Paris F, Cordon-Cardo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003; 300 (5622): 1155-1159. (Pubitemid 36583102)
17. Greenfi eld JP, Cobb WS, Lyden D. Resisting arrest: a switch from angiogenesis to vasculogenesis in recurrent malignant gliomas. J Clin Invest. 2010; 120 (3): 663-667.
18. Ogawa K, Boucher Y, Kashiwagi S, Fukumura D, Chen D, Gerweck LE. Infl uence of tumor cell and stroma sensitivity on tumor response to radiation. Cancer Res. 2007; 67 (9): 4016-4021. (Pubitemid 46815045)
19. Kozin SV, Duda DG, Munn LL, Jain RK. Is vasculogenesis crucial for the regrowth of irradiated tumours? Nat Rev Cancer. 2011; 11 (7): 532.
20. Song CW, Levitt SH. Vascular changes in Walker 256 carcinoma of rats following x irradiation. Radiology. 1971; 100 (2): 397-407.
21. Song CW, Payne JT, Levitt SH. Vascularity and blood fl ow in x-irradiated Walker carcinoma 256 of rats. Radiology. 1972; 104 (3): 693-697.
22. Kallman RF, DeNardo GL, Stasch MJ. Blood fl ow in irradiated mouse sarcoma as determined by the clearance of xenon-133. Cancer Res. 1972; 32 (3): 483-490.
23. Song CW, Sung JH, Clement JJ, Levitt SH. Vascular changes in neuroblastoma of mice following x-irradiation. Cancer Res. 1974; 34 (9): 2344-2350.
24. Hilmas DE, Gillette EL. Morphometric analyses of the microvasculature of tumors during growth and after x-irradiation. Cancer. 1974; 33 (1): 103-110.
25. Hilmas DE, Gillette EL. Microvasculature of C3H/Bi mouse mammary tumors after x-irradiation. Radiat Res. 1975; 61 (1): 128-143.
26. Solesvik OV, Rofstad EK, Brustad T. Vascular changes in a human malignant melanoma xenograft following single-dose irradiation. Radiat Res. 1984; 98 (1): 115-128. (Pubitemid 14106046)
27. Spence AM, Graham MM, Abbott GL, Muzi M, Lewellen TK. Blood fl ow changes following 137Cs irradiation in a rat glioma model. Radiat Res. 1988; 115 (3): 586-594.
28. Tozer GM, Bhujwalla ZM, Griffi ths JR, Maxwell RJ. Phosphorus-31 magnetic resonance spectroscopy and blood perfusion of the RIF-1 tumor following X-irradiation. Int J Radiat Oncol Biol Phys. 1989; 16 (1): 155-164. (Pubitemid 19045348)
29. Kalofonos H, Rowlinson G, Epenetos AA. Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation. Cancer Res. 1990; 50 (1): 159-163. (Pubitemid 20030011)
30. Tozer GM, Myers R, Cunningham VJ. Radiation-induced modifi cation of blood fl ow distribution in a rat fi brosarcoma. Int J Radiat Biol. 1991; 60 (1-2): 327-334.
31. Garcia-Barros M, Thin TH, Maj J, et al. Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited. Cancer Res. 2010; 70 (20): 8179-8186.
32. Horsman MR, Nielsen T, Ostergaard L, Overgaard J. Radiation administered as a large single dose or in a fractionated schedule: role of the tumour vasculature as a target for infl uencing response. Acta Oncol. 2006; 45 (7): 876-880. (Pubitemid 44423135)
33. Ljungkvist AS, Bussink J, Kaanders JH, Wiedenmann NE, Vlasman R, van der Kogel AJ. Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model. Radiat Res. 2006; 165 (3): 326-336.
34. Itasaka S, Komaki R, Herbst RS, et al. Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice. Int J Radiat Oncol Biol Phys. 2007; 67 (3): 870-878. (Pubitemid 46215889)
35. Zeng L, Ou G, Itasaka S, et al. TS-1 enhances the effect of radiotherapy by suppressing radiation-induced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis. Cancer Sci. 2008; 99 (11): 2327-2335.
36. Chen FH, Chiang CS, Wang CC, et al. Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors. Clin Cancer Res. 2009; 15 (5): 1721-1729.
37. Fokas E, Hanze J, Kamlah F, et al. Irradiation-dependent effects on tumor perfusion and endogenous and exogenous hypoxia markers in an A549 xenograft model. Int J Radiat Oncol Biol Phys. 2010; 77 (5): 1500-1508.
38. Newcomb EW, Lukyanov Y, Alonso-Basanta M, et al. Antiangiogenic effects of noscapine enhance radioresponse for GL261 tumors. Int J Radiat Oncol Biol Phys. 2008; 71 (5): 1477-1484. (Pubitemid 351978170)
39. Tsai JH, Makonnen S, Feldman M, Sehgal CM, Maity A, Lee WM. Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis. Cancer Biol Ther. 2005; 4 (12): 1395-1400. (Pubitemid 43131187)
40. Kozin SV, Winkler F, Garkavtsev I, Hicklin DJ, Jain RK, Boucher Y. Human tumor xenografts recurring after radiotherapy are more sensitive to anti-vascular endothelial growth factor receptor-2 treatment than treatment-naive tumors. Cancer Res. 2007; 67 (11): 5076-5082. (Pubitemid 46997241)
41. Nojiri K, Iwakawa M, Ichikawa Y, et al. The proangiogenic factor ephrin-A1 is up-regulated in radioresistant murine tumor by irradiation. Exp Biol Med (Maywood). 2009; 234 (1): 112-122.
42. Brown JM, Koong AC. High-dose single-fraction radiotherapy: exploiting a new biology? Int J Radiat Oncol Biol Phys. 2008; 71 (2): 324-325. (Pubitemid 351636202)
43. Lo SS, Fakiris AJ, Chang EL, et al. Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol. 2010; 7 (1): 44-54.
44. Tipton K, Launders JH, Inamdar R, Miyamoto C, Schoelles K. Stereotactic body radiation therapy: scope of the literature. Ann Intern Med. 2011; 154 (11): 737-745.
45. Burdelya LG, Komarova EA, Hill JE, et al. Inhibition of p53 response in tumor stroma improves effi cacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice. Cancer Res. 2006; 66 (19): 9356-9361. (Pubitemid 44623629)
46. Baeten CI, Castermans K, Lammering G, et al. Effects of radiotherapy and chemotherapy on angiogenesis and leukocyte infi ltration in rectal cancer. Int J Radiat Oncol Biol Phys. 2006; 66 (4): 1219-1227. (Pubitemid 44633532)
47. Wurschmidt F, Beck-Bornholdt HP, Vogler H. Radiobiology of the rhabdomyosarcoma R1H of the rat: infl uence of the size of irradiation fi eld on tumor response, tumor bed effect, and neovascularization kinetics. Int J Radiat Oncol Biol Phys. 1990; 18 (4): 879-882. (Pubitemid 20154047)
48. Kim JJ, Tannock IF. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer. 2005; 5 (7): 516-525. (Pubitemid 40942828)
49. Milas L, Milas M. Tumor bed phenomenon: effect on tumor progression and therapy. In: Rubin DB, ed. The Radiation Biology of the Vascular Endothelium. Boca Raton, FL : CRC Press LLC; 1998 : 209-229.
50. Sonveaux P, Brouet A, Havaux X, et al. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Res. 2003; 63 (5): 1012-1019. (Pubitemid 36278432)
51. Endrich B, Reinhold HS, Gross JF, Intaglietta M. Tissue perfusion inhomogeneity during early tumor growth in rats. J Natl Cancer Inst. 1979; 62 (2): 387-395. (Pubitemid 9094732)
52. Gee MS, Procopio WN, Makonnen S, Feldman MD, Yeilding NM, Lee WM. Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy. Am J Pathol. 2003; 162 (1): 183-193. (Pubitemid 36042000)
53. Giatromanolaki A, Sivridis E, Koukourakis MI. Tumour angiogenesis: vascular growth and survival. Apmis. 2004; 112 (7-8): 431-440. (Pubitemid 39626051)
54. Tilki D, Kilic N, Sevinc S, Zywietz F, Stief CG, Ergun S. Zone-specifi c remodeling of tumor blood vessels affects tumor growth. Cancer. 2007; 110 (10): 2347-2362. (Pubitemid 350100758)
55. Eddy HA. Tumor vascular responses following irradiation. Microvasc Res. 1980; 20 (2): 195-211. (Pubitemid 11146430)
56. Yamaura H, Matsuzawa T. Tumor regrowth after irradiation; an experimental approach. Int J Radiat Biol Relat Stud Phys Chem Med. 1979; 35 (3): 201-219. (Pubitemid 9145849)
57. Dewhirst MW. Intermittent hypoxia furthers the rationale for hypoxiainducible factor-1 targeting. Cancer Res. 2007; 67 (3): 854-855.
58. Hlushchuk R, Riesterer O, Baum O, et al. Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation. Am J Pathol. 2008; 173 (4): 1173-1185.
59. Takahashi Y, Teshima T, Kawaguchi N, et al. Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. Cancer Res. 2003; 63 (14): 4253-4257. (Pubitemid 36917954)
60. Grabham P, Hu B, Sharma P, Geard C. Effects of ionizing radiation on three-dimensional human vessel models: differential effects according to radiation quality and cellular development. Radiat Res. 2011; 175 (1): 21-28.
61. Fidler IJ. Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment. J Natl Cancer Inst. 2001; 93 (14): 1040-1041. (Pubitemid 32717529)
62. Talmadge JE, Singh RK, Fidler IJ, Raz A. Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol. 2007; 170 (3): 793-804. (Pubitemid 47339349)
63. Sajithlal GB, McGuire TF, Lu J, Beer-Stolz D, Prochownik EV. Endothelial-like cells derived directly from human tumor xenografts. Int J Cancer. 2010; 127 (10): 2268-2278.
64. Ricci-Vitiani L, Pallini R, Biffoni M, et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature. 2010; 468 (7325): 824-828.
65. Soda Y, Marumoto T, Friedmann-Morvinski D, et al. Feature article: transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci USA. 2011; 108 (11): 4274-4280.
66. Wang R, Chadalavada K, Wilshire J, et al. Glioblastoma stem-like cells give rise to tumour endothelium. Nature. 2010; 468 (7325): 829-833.
67. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011; 473 : 298-307.
68. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444 (7120): 756-760. (Pubitemid 44949604)
69. Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer. 2008; 8 (7): 545-554. (Pubitemid 351881850)
70. Ergun S, Hohn HP, Kilic N, Singer BB, Tilki D. Endothelial and hematopoietic progenitor cells (EPCs and HPCs): hand in hand fate determining partners for cancer cells. Stem Cell Rev. 2008; 4 (3): 169-177.
71. Aicher A, Rentsch M, Sasaki K, et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res. 2007; 100 (4): 581-589. (Pubitemid 46673268)